Severe Hemorrhagic Fever in Strain 13/N Guinea Pigs Infected with Lujo Virus

PLoS Neglected Tropical Diseases

Volumn 6, Issue 8, 2012, Pages

  Bird, Brian H ^a   Dodd, Kimberly A ^a,b   Erickson, Bobbie R ^a   Albariño, César G ^a   Chakrabarti, Ayan K ^a   McMullan, Laura K ^a   Bergeron, Eric ^a   Ströeher, Ute ^a   Cannon, Deborah ^a   Martin, Brock ^a   Coleman McCray, JoAnn D ^a   Nichol, Stuart T ^a   Spiropoulou, Christina F ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARENAVIRUS; ARTICLE; BODY POSTURE; BODY TEMPERATURE; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; EXPERIMENTAL MODEL; EYE DISCHARGE; FEMALE; GUINEA PIG; HAIR DISEASE; HEMATOLOGICAL PARAMETERS; HEMORRHAGIC FEVER; HISTOLOGY; LETHARGY; LUJO VIRUS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS TRANSMISSION; WEIGHT REDUCTION;

ANIMAL STRUCTURES; ANIMALS; ARENAVIRIDAE INFECTIONS; ARENAVIRUS; BLOOD COAGULATION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; GUINEA PIGS; HEMORRHAGIC FEVERS, VIRAL; HUMANS; LEUKOPENIA; LYMPHOPENIA; MALE; MICE; PREGNANCY; SURVIVAL ANALYSIS; THROMBOCYTOPENIA; TRANSAMINASES;

EID: 84865986802     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001801     Document Type: Article

References (62)

1. Armstrong C, Lillie RD, (1934) Experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1933 St. Louis encephalitis epidemic. Public Health Reports pp. 1019--1027.
2. Webb PA, Johnson KM, Mackenzie RB, Kuns ML, (1967) Some characteristics of Machupo virus, causative agent of Bolivian hemorrhagic fever. American Journal of Tropical Medicine & Hygiene 16: 531-538.
3. Armstrong D, Fortner JG, Rowe WP, Parker JC, (1969) Meningitis due to lymphocytic choriomeningitis virus endemic in a hamster colony. Jama 209: 265--267.
4. Frame JD, Baldwin JM Jr, Gocke DJ, Troup JM, (1970) Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 19: 670--676.
5. Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, et al. (1973) A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg 22: 773--779.
6. Parodi AS, Greenway DJ, Rugiero HR, Frigerio M, De La Barrera JM, et al. (1958) Concerning the epidemic outbreak in Junin. El Dia medico 30: 2300-2301.
7. Salas R, de Manzione N, Tesh RB, Rico-Hesse R, Shope RE, et al. (1991) Venezuelan haemorrhagic fever. Lancet 338: 1033--1036.
8. Lisieux T, Coimbra M, Nassar ES, Burattini MN, de Souza LT, et al. (1994) New arenavirus isolated in Brazil. Lancet 343: 391--392.
9. Delgado S, Erickson BR, Agudo R, Blair PJ, Vallejo E, et al. (2008) Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog 4: e1000047.
10. Bausch DG, Demby AH, Coulibaly M, Kanu J, Goba A, et al. (2001) Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne & Zoonotic Diseases 1: 269-281.
11. Emonet SE, Urata S, de la Torre JC, (2011) Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology 411: 416--425.
12. Berge TO, Taylor RM, Karabatsos N, (1985) International catalogue of arboviruses, 1985: including certain other viruses of vertebrates: Published for the Subcommittee on Information Exchange of the American Committee on Arthropod-borne Viruses by the American Society of Tropical Medicine and Hygiene.
13. Buchmeier MJ, Peters CJ, de la Torre JC (2007) Arenaviridae: the viruses and their replication. In: Knipe DMaH, P.M., editor. Fields Virology. 5th ed. Philadelphia: Lippincott, Williams and Wilkins. pp. 1792-1827.
14. Childs JP, (1993) Ecology and epidemiology of arenaviruses and their hosts; Salvato MS, editor: Plenum Press.
15. Barton LL, Mets MB, Beauchamp CL, (2002) Lymphocytic choriomeningitis virus: emerging fetal teratogen. American Journal of Obstetrics & Gynecology 187: 1715-1716.
16. Centers for Disease Control and P (2005) Lymphocytic choriomeningitis virus infection in organ transplant recipients-Massachusetts, Rhode Island, 2005. MMWR- Morbidity & Mortality Weekly Report 54: 537--539.
17. Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, et al. (2006) Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 354: 2235--2249.
18. Amman BR, Pavlin BI, Albarino CG, Comer JA, Erickson BR, et al. (2007) Pet rodents and fatal lymphocytic choriomeningitis in transplant patients. Emerg Infect Dis 13: 719--725.
19. Meritet JF, Krivine A, Lewin F, Poissonnier MH, Poizat R, et al. (2009) A case of congenital lymphocytic choriomeningitis virus (LCMV) infection revealed by hydrops fetalis. Prenat Diagn 29: 626--627.
20. Barton LL, Hyndman NJ, (2000) Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen. Pediatrics 105: E35.
21. Martinez-Sobrido L, Emonet S, Giannakas P, Cubitt B, Garcia-Sastre A, et al. (2009) Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 83: 11330--11340.
22. McCormick JB, Fisher-Hoch SP, (2002) Lassa fever. Curr Top Microbiol Immunol 262: 75--109.
23. Peters CJ, (2002) Human infection with arenaviruses in the Americas. Current Topics in Microbiology & Immunology 262: 65-74.
24. Borrow P, Martinez-Sobrido L, de la Torre JC, (2010) Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses 2: 2443--2480.
25. Fan L, Briese T, Lipkin WI, (2010) Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J Virol 84: 1785--1791.
26. Hastie KM, Kimberlin CR, Zandonatti MA, MacRae IJ, Saphire EO, (2011) Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3′ to 5′ exonuclease activity essential for immune suppression. Proc Natl Acad Sci U S A 108: 2396-2401.
27. Ales NC, Katial RK, (2004) Vaccines against biologic agents: uses and developments. Respiratory Care Clinics of North America 10: 123--146.
28. Fisher-Hoch SP, McCormick JB, (2004) Lassa fever vaccine. Expert Rev Vaccines 3: 189--197.
29. Kunz S, de la Torre JC, (2005) Novel antiviral strategies to combat human Arenavirus infections. Current Molecular Medicine 5: 735--751.
30. Lee AM, Pasquato A, Kunz S, (2011) Novel approaches in anti-arenaviral drug development. Virology 411: 163--169.
31. McKee KT Jr, Oro JG, Kuehne AI, Spisso JA, Mahlandt BG, (1992) Candid No. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in rhesus macaques. Intervirology 34: 154--163.
32. Enria DA, Barrera Oro JG, (2002) Junin virus vaccines. Curr Top Microbiol Immunol 263: 239--261.
33. Bausch DG, Hadi CM, Khan SH, Lertora JJ, (2010) Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for lassa Fever. Clin Infect Dis 51: 1435--1441.
34. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, et al. (1986) Lassa fever. Effective therapy with ribavirin. N Engl J Med 314: 20--26.
35. Boxaca MC, Parodi AS, Rugiero H, Blay R, (1961) Experimental hemorrhagic fever in the guinea pig (Junin virus). Rev Soc Argent Biol 37: 170-179.
36. Walker DH, Wulff H, Lange JV, Murphy FA, (1975) Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis. Bull World Health Organ 52: 523--534.
37. Jahrling PB, Smith S, Hesse RA, Rhoderick JB, (1982) Pathogenesis of Lassa virus infection in guinea pigs. Infect Immun 37: 771--778.
38. Hall WC, Geisbert TW, Huggins JW, Jahrling PB, (1996) Experimental infection of guinea pigs with Venezuelan hemorrhagic fever virus (Guanarito): a model of human disease. American Journal of Tropical Medicine & Hygiene 55: 81-88.
39. Liang Y, Lan S, Ly H, (2009) Molecular determinants of Pichinde virus infection of guinea pigs-a small animal model system for arenaviral hemorrhagic fevers. Ann N Y Acad Sci 1171 Suppl 1: E65--74.
40. Webster JM, Kirk BE, (1974) Neutralizing antibody response of guinea pigs to lymphocytic choriomeningitis virus. Infect Immun 10: 516--519.
41. Laguens RM, Avila MM, Samoilovich SR, Weissenbacher MC, Laguens RP, (1983) Pathogenicity of an attenuated strain (XJCl3) of Junin virus. Morphological and virological studies in experimentally infected guinea pigs. Intervirology 20: 195--201.
42. Oubina JR, Carballal G, Videla CM, Cossio PM, (1984) The guinea pig model for Argentine hemorrhagic fever. American Journal of Tropical Medicine & Hygiene 33: 1251-1257.
43. Qian C, Jahrling PB, Peters CJ, Liu CT, (1994) Cardiovascular and pulmonary responses to Pichinde virus infection in strain 13 guinea pigs. Lab Anim Sci 44: 600--607.
44. Yun NE, Linde NS, Dziuba N, Zacks MA, Smith JN, et al. (2008) Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs. Am J Trop Med Hyg 79: 275--282.
45. Care CftUotGft, Animals UoL, Council NR (2011) Guide for the Care and Use of Laboratory Animals: Eighth Edition: The National Academies Press.
46. Albarino CG, Bird BH, Chakrabarti AK, Dodd KA, Erickson BR, et al. (2011) Efficient rescue of recombinant Lassa virus reveals the influence of S segment noncoding regions on virus replication and virulence. J Virol 85: 4020--4024.
47. Albarino CG, Bird BH, Chakrabarti AK, Dodd KA, Flint M, et al. (2011) The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain. J Virol 85: 10404--10408.
48. Santangelo KS, Bertone AL, (2011) Effective reduction of the interleukin-1beta transcript in osteoarthritis-prone guinea pig chondrocytes via short hairpin RNA mediated RNA interference influences gene expression of mediators implicated in disease pathogenesis. Osteoarthritis Cartilage 19: 1449--1457.
49. Santangelo KS, Pieczarka EM, Nuovo GJ, Weisbrode SE, Bertone AL, (2011) Temporal expression and tissue distribution of interleukin-1beta in two strains of guinea pigs with varying propensity for spontaneous knee osteoarthritis. Osteoarthritis Cartilage 19: 439--448.
50. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101--1108.
51. McCormick JB, (1988) Lassa fever: epidemiology, therapy and vaccine development. Kansenshogaku Zasshi 62 Suppl: 353--366.
52. Briese T, Paweska JT, McMullan LK, Hutchison SK, Street C, et al. (2009) Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog 5: e1000455.
53. Gunther S, Lenz O, (2004) Lassa virus. Critical Reviews in Clinical Laboratory Sciences 41: 339--390.
54. Harrison LH, Halsey NA, McKee KT Jr, Peters CJ, Barrera Oro JG, et al. (1999) Clinical case definitions for Argentine hemorrhagic fever. Clin Infect Dis 28: 1091--1094.
55. Albarino CG, Bird BH, Chakrabarti AK, Dodd KA, White DM, et al. (2011) Reverse genetics generation of chimeric infectious Junin/Lassa virus is dependent on interaction of homologous glycoprotein stable signal peptide and G2 cytoplasmic domains. J Virol 85: 112--122.
56. Gowen BB, Holbrook MR, (2008) Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses. Antiviral Res 78: 79--90.
57. Moraz ML, Kunz S, (2011) Pathogenesis of arenavirus hemorrhagic fevers. Expert Rev Anti Infect Ther 9: 49--59.
58. Flatz L, Rieger T, Merkler D, Bergthaler A, Regen T, et al. (2010) T cell-dependence of Lassa fever pathogenesis. PLoS Pathog 6: e1000836.
59. Baize S, Kaplon J, Faure C, Pannetier D, Georges-Courbot MC, et al. (2004) Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. Journal of Immunology 172: 2861--2869.
60. Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, et al. (2003) Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol 170: 2797--2801.
61. Mahanty S, Bausch DG, Thomas RL, Goba A, Bah A, et al. (2001) Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. The Journal of infectious diseases 183: 1713--1721.
62. Peters CJ, Liu CT, Anderson GW Jr, Morrill JC, Jahrling PB, (1989) Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Reviews of Infectious Diseases 11 Suppl 4: S743--749.